 |
|
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Synonyms: | Dromostanolone Enanthate | Assay: | 99% Min |
|---|---|---|---|
| Molecular Formula: | C23H36O3 | Molecular Weight: | 360 |
| Delivery: | Express Courier | Character: | White Crystalline Powder |
| High Light: | Legal Injectable Steroids,Natural Anabolic Steroids |
||
Injectable Anabolic Steroide Drostanolone Enanthate 200 CAS No 472-61-145 for Muscle Gains
Description:
Drostanolone enanthate is an ester of drostanolone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in combined hormone therapy. Drostanolone causes retention of nitrogen, potassium, and phosphorus; Increases protein anabolism; And decreases amino acid catabolism.
The antitumor activity of drostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.
Drostanolone enanthate 200 USP injection provides drostanolone enanthate, a potent androgenic steroid that has similar characteristics of dihydrotestosterone. Drostanolone is incapable of aromization and therefore it doesn't convert into oestrogen. Both drostanolone's anabolic and androgenic activity are far greater than methyl testosterone. The esterification of the 17-beta-hydroxyl group increases the duration of the action of drostanolone. Drostanolone esters in oil injected intramuscularly are absorbed slowly from the lipid phase, thus Drostanolone enanthate 200 can be administered at intervals of every 1-2 weeks.
Drostanolone enanthate 200 contains drostanolone enanthate in a 10ml solution for injection (200mg drostanolone enanthate /ml).
Drostanolone enanthate 200 is a yellowish oily solution for intramuscular injection.
Drostanolone enanthate is an ester of drostanolone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in combined hormone therapy. Drostanolone causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism.
The antitumor activity of drostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.
Drostanolone enanthate 200 USP injection provides drostanolone enanthate, a potent androgenic steroid that has similar characteristics of dihydrotestosterone. Drostanolone is incapable of aromization and therefore it doesn't convert into oestrogen. Both drostanolone's anabolic and androgenic activity are far greater than methyl testosterone. The esterification of the 17-beta-hydroxyl group increases the duration of the action of drostanolone. Drostanolone esters in oil injected intramuscularly are absorbed slowly from the lipid phase, thus Drostanolone enanthate 200 can be administered at intervals of every 1-2 weeks
COA:
| Test | Analysis Standard |
Results |
Description |
White Or Almost White Crystalline Powder |
White Crystalline Powder |
Melting Point |
63ºC-69ºC |
65ºC-68ºC |
Specific Rotation |
+20º-+30º |
+25.6° |
Loss On Drying |
≤0.5% |
0.32% |
Residue On Ignition |
≤0.1% |
0.02% |
Assay |
≥97% |
98.7% |
Conclusion |
Be Conform With Enterprise Standard |
|
Related product:
| Testosterone Enanthate | CAS: 315-37-7 |
| Testosterone Propionate | CAS: 57-85-2 |
| Testosterone Sustanon 250 | Null |
| Testosterone Cypionate | CAS: 58-20-8 |
| Trenbolone Acetate | CAS: 10161-34-9 |
| Trenbolone Enanthate | CAS: 10161-33-8 |
| Drostanolone Propionate (Masteron) | CAS: 521-12-0 |
| Drostanolone Enanthate | CAS: 472-61-145 |
| Boldenone Undecylenate(Equipoise) | CAS: 13103-34-9 |
| Nandrolone Decanoate | CAS: 360-70-3 |
| Nandrolone Phenylpropionate | CAS: 62-90-8 |
| Anavar | CAS: 53-39-4 |
| Dianabol | CAS: 72-63-9 |
| Winstrol | CAS: 10418-03-8 |
| Anadrol | CAS: 434-07-1 |
| Methenolone Enanthate (Primobolan) | CAS: 303-42-4 |
| Methenolone Acetate | CAS: 434-05-9 |
| Turinabol | CAS: 855-19-6 |
Contact Person: Sales Manager
Tel: +8613429837396
